trial · primary record
zagociguat 15mg
Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
| Phase | Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 37 |
| Primary completion | 2026-10-26 |
| Primary endpoint | Incidence of Treatment-emergent Adverse Events (TEAEs) |
| Registry ID | NCT06961344 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:22.851Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06961344
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.